Synergy Pharmaceuticals Wins Ch. 11 Plan Approval
Synergy Pharmaceuticals Inc. received court approval Tuesday to wind down in Chapter 11 under a bankruptcy plan that provides creditors with recoveries from a $195 million sale of the company's drug...To view the full article, register now.
Already a subscriber? Click here to view full article